Single-dose HPV vaccination efficacy among adolescent girls and young women in Kenya (the KEN SHE Study): study protocol for a randomized controlled trial

Single-dose HPV vaccination efficacy among adolescent girls and young women in Kenya (the KEN SHE Study): study protocol for a randomized controlled trial

Abstract Background HPV infection is the primary cause of cervical cancer, a leading cause of cancer among women in Kenya and many sub-Saharan African countries. High coverage of HPV vaccination is a World Health Organization priority to eliminate cervical cancer globally, but vaccine supply and log...

Full description

Bibliographic Details
Main Authors: Ruanne V. Barnabas, Elizabeth R. Brown, Maricianah Onono, Elizabeth A. Bukusi, Betty Njoroge, Rachel L. Winer, Deborah Donnell, Denise Galloway, Stephen Cherne, Kate Heller, Hannah Leingang, Susan Morrison, Elena Rechkina, R. Scott McClelland, Jared M. Baeten, Connie Celum, Nelly Mugo, for the KEN SHE Study Team
Format: Article
Language:English
Published: BMC 2021-09-01
Series:Trials
Subjects:
Human papillomavirus
Randomized controlled trial
Single-dose vaccination
Reduced dose schedule
Multi-age cohort
Online Access:https://doi.org/10.1186/s13063-021-05608-8

Internet

https://doi.org/10.1186/s13063-021-05608-8

Similar Items